MedImmune spin-off Viela Bio to locate in Gaithersburg, create 100 jobs

SourceThe Baltimore Sun
Date Published02/28/2018
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Viela Bio
Parent companyMedImmune
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):100
Capital investment ($):250
Country(ies) from which reshored:United Kingdom
City reshored to:Gaithersburg
State(s) reshored to:MD
If relevant, work nearshored to:-
Product(s) reshoredpharmaceuticals
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, Proximity to customers/market
Government Incentive dollar amount:3
Find Reshoring Articles